• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.医院普通内科病房中值得向药品安全委员会通报的药品不良反应。
Br J Clin Pharmacol. 1996 Oct;42(4):423-9. doi: 10.1046/j.1365-2125.1996.04376.x.
2
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
3
The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme.护士参与报告疑似药物不良反应:脑膜炎球菌疫苗接种计划的经验
Br J Clin Pharmacol. 2003 Dec;56(6):658-63. doi: 10.1046/j.1365-2125.2003.01903.x.
4
Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.英国执业医师药品不良反应报告态度调查
Br J Clin Pharmacol. 1995 Mar;39(3):223-6. doi: 10.1111/j.1365-2125.1995.tb04440.x.
5
Review of yellow cards (1986): report to the Committee on the Safety of Medicines.
Br J Clin Pharmacol. 1988 Dec;26(6):679-89. doi: 10.1111/j.1365-2125.1988.tb05305.x.
6
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.英国本科医学和药学课程中的药物不良反应教学。
J Clin Pharm Ther. 2004 Feb;29(1):31-5. doi: 10.1046/j.1365-2710.2003.00533.x.
7
The incidence and reporting of adverse drug reactions in the Division of Psychiatry.
Pharm World Sci. 2001 Oct;23(5):181-2. doi: 10.1023/a:1012283406315.
8
Prescription-event monitoring and reporting of adverse drug reactions.处方事件监测与药品不良反应报告。
Lancet. 2001 Dec 1;358(9296):1872-3. doi: 10.1016/S0140-6736(01)06898-2.
9
A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.一项关于英国医院药剂师认为可能影响药品不良反应报告的因素的调查。
Drug Saf. 2000 Aug;23(2):165-72. doi: 10.2165/00002018-200023020-00006.
10
Nurse reporting of adverse events caused by medicines.护士对药物所致不良事件的报告。
Nurs Times. 2003;99(49):24-5.

引用本文的文献

1
Tyrosine Kinase Inhibitors and Interstitial Lung Disease: A Disproportionality Analysis Using the European Post-marketing EudraVigilance Database.酪氨酸激酶抑制剂与间质性肺病:使用欧洲上市后药物警戒数据库进行的不成比例性分析
Drugs Real World Outcomes. 2025 Sep 2. doi: 10.1007/s40801-025-00515-9.
2
Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey.动机与知识的葡萄牙社区药剂师对报告可疑药品不良反应:一个横断面调查。
J Community Health. 2023 Apr;48(2):295-308. doi: 10.1007/s10900-022-01168-3. Epub 2022 Nov 19.
3
Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals' Perspectives on How to Improve Reporting.芬兰药品不良反应报告不足以及医疗保健专业人员对如何改进报告的看法
Healthcare (Basel). 2022 May 31;10(6):1015. doi: 10.3390/healthcare10061015.
4
A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.基于英国药物警戒和英格兰一般实践处方数据的药品比较安全性分析。
In Vivo. 2022 Mar-Apr;36(2):780-800. doi: 10.21873/invivo.12765.
5
Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia.沙特阿拉伯一家三级护理医院医生对药物不良反应报告的认知与障碍
Hosp Pharm. 2021 Aug;56(4):368-373. doi: 10.1177/0018578720910385. Epub 2020 Mar 4.
6
Knowledge, attitude, practices, and barriers regarding pharmacovigilance and adverse drug reaction reporting among medical and dental faculties of the teaching hospitals in Bhubaneswar City.布巴内斯瓦尔市教学医院医学和牙医学系在药物警戒及药品不良反应报告方面的知识、态度、做法和障碍。
J Educ Health Promot. 2020 Oct 30;9:282. doi: 10.4103/jehp.jehp_250_20. eCollection 2020.
7
Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study.印度阿姆拉瓦蒂地区的药物不良反应概况:一项药物警戒研究。
J Pharm Bioallied Sci. 2020 Apr-Jun;12(2):155-162. doi: 10.4103/jpbs.JPBS_226_19. Epub 2020 Apr 10.
8
Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.一项调查,评估自2012年以来支持欧盟上市后药品撤市、撤销和暂停上市许可的公开可用证据。
BMJ Open. 2018 Jan 23;8(1):e019759. doi: 10.1136/bmjopen-2017-019759.
9
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts.评估脸书和推特监测以检测医疗产品安全信号:对美国食品药品监督管理局近期安全警报的分析
Drug Saf. 2017 Apr;40(4):317-331. doi: 10.1007/s40264-016-0491-0.
10
Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.主动式区域药物警戒系统与国家自发报告在收集关于可疑超说明书用药行为安全性数据方面的比较:以法国巴氯芬与酒精依赖为例
Drug Saf. 2017 Mar;40(3):257-262. doi: 10.1007/s40264-016-0489-7.

医院普通内科病房中值得向药品安全委员会通报的药品不良反应。

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.

作者信息

Smith C C, Bennett P M, Pearce H M, Harrison P I, Reynolds D J, Aronson J K, Grahame-Smith D G

机构信息

Oxford Regional Drug Information Unit, John Radcliffe Hospital, Headington, UK.

出版信息

Br J Clin Pharmacol. 1996 Oct;42(4):423-9. doi: 10.1046/j.1365-2125.1996.04376.x.

DOI:10.1046/j.1365-2125.1996.04376.x
PMID:8904613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2042689/
Abstract
  1. We have retrospectively analysed data collected by a local adverse drug reactions reporting scheme in an acute hospital medical setting and have determined the numbers and types of reactions that would have merited notification as yellow card reports according to the guidelines of the Committee on Safety of Medicines. 2. The data related to 20,695 consecutive acute general medical admissions on seven general medical wards (140 beds) and were collected over 3 years, from April 1990 to March 1993. 3. Over 3 years there were 1420 reports of suspected adverse drug reactions, a rate of 68.7 per 1000 admissions. 4. If the guidelines for reporting issued by the Committee on Safety of Medicines had been strictly followed, 477 yellow cards would have been sent (23.1 per 1000 admissions). In 357 of these reports (74.8%), the reaction had caused admission to hospital. Only 31 of the 477 potential cards (6.5%) involved black triangle drugs and 10 of these were for minor reactions. 5. Only 30 of the 477 potential yellow cards (6.3%) were known to have been sent. The majority of those reactions not reported were for drug-related admissions, most of which were for well-known reactions to established drugs. 6. We have confirmed and quantified the extent of under-reporting of serious suspected adverse drug reactions to the Committee on Safety of Medicines from our hospital medical unit.
摘要
  1. 我们回顾性分析了一家急症医院内科环境中通过当地药品不良反应报告计划收集的数据,并根据药品安全委员会的指南确定了值得作为黄牌报告进行通报的反应数量和类型。2. 这些数据与七个普通内科病房(140张床位)连续20,695例急性普通内科住院病例相关,收集时间为1990年4月至1993年3月的三年间。3. 在这三年中,有1420例疑似药品不良反应报告,报告率为每1000例住院病例中有68.7例。4. 如果严格遵循药品安全委员会发布的报告指南,将会发出477张黄牌(每1000例住院病例中有23.1例)。在这些报告中的357例(74.8%)中,反应导致了住院。477张潜在黄牌中只有31例(6.5%)涉及黑三角药品,其中10例为轻微反应。5. 477张潜在黄牌中只有30例(6.3%)已知已被发出。那些未报告的反应大多数与药物相关的住院有关,其中大多数是对已上市药物的已知反应。6. 我们已经确认并量化了我们医院内科单元向药品安全委员会严重疑似药品不良反应报告不足的程度。